Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 07, 2024

SELL
$11.51 - $21.53 $56,537 - $105,755
-4,912 Reduced 13.95%
30,292 $354,000
Q1 2024

May 03, 2024

BUY
$12.17 - $24.61 $5,561 - $11,246
457 Added 1.32%
35,204 $741,000
Q4 2023

Feb 08, 2024

BUY
$12.89 - $20.82 $5,336 - $8,619
414 Added 1.21%
34,747 $623,000
Q3 2023

Nov 09, 2023

BUY
$16.46 - $19.99 $17,299 - $21,009
1,051 Added 3.16%
34,333 $565,000
Q2 2023

Aug 07, 2023

BUY
$17.23 - $21.71 $49,743 - $62,676
2,887 Added 9.5%
33,282 $665,000
Q1 2023

May 01, 2023

BUY
$18.08 - $24.55 $51,527 - $69,967
2,850 Added 10.35%
30,395 $574,000
Q4 2022

Feb 07, 2023

BUY
$20.4 - $24.73 $10,057 - $12,191
493 Added 1.82%
27,545 $625,000
Q3 2022

Oct 25, 2022

SELL
$22.29 - $35.04 $8,537 - $13,420
-383 Reduced 1.4%
27,052 $715,000
Q2 2022

Aug 08, 2022

BUY
$19.35 - $35.04 $14,551 - $26,350
752 Added 2.82%
27,435 $678,000
Q1 2022

May 06, 2022

SELL
$24.62 - $34.31 $11,128 - $15,508
-452 Reduced 1.67%
26,683 $886,000
Q4 2021

Feb 08, 2022

SELL
$30.19 - $40.28 $18,023 - $24,047
-597 Reduced 2.15%
27,135 $887,000
Q3 2021

Oct 28, 2021

BUY
$29.09 - $45.68 $51,052 - $80,168
1,755 Added 6.76%
27,732 $1.16 Million
Q2 2021

Jul 27, 2021

SELL
$32.46 - $40.48 $1,882 - $2,347
-58 Reduced 0.22%
25,977 $1.01 Million
Q1 2021

May 03, 2021

BUY
$33.61 - $49.95 $67,421 - $100,199
2,006 Added 8.35%
26,035 $888,000
Q4 2020

Feb 04, 2021

SELL
$26.52 - $49.35 $102,526 - $190,787
-3,866 Reduced 13.86%
24,029 $1.09 Million
Q3 2020

Nov 06, 2020

BUY
$27.01 - $40.26 $77,923 - $116,150
2,885 Added 11.54%
27,895 $768,000
Q2 2020

Aug 04, 2020

SELL
$27.75 - $43.44 $45,010 - $70,459
-1,622 Reduced 6.09%
25,010 $921,000
Q1 2020

Apr 27, 2020

BUY
$21.5 - $54.2 $111,649 - $281,460
5,193 Added 24.22%
26,632 $862,000
Q4 2019

Feb 03, 2020

BUY
$34.54 - $44.87 $5,008 - $6,506
145 Added 0.68%
21,439 $878,000
Q3 2019

Oct 31, 2019

BUY
$31.84 - $50.88 $12,990 - $20,759
408 Added 1.95%
21,294 $758,000
Q2 2019

Aug 09, 2019

BUY
$42.0 - $59.29 $4,830 - $6,818
115 Added 0.55%
20,886 $1.07 Million
Q1 2019

May 02, 2019

BUY
$40.82 - $62.45 $43,677 - $66,821
1,070 Added 5.43%
20,771 $1.19 Million
Q4 2018

Feb 11, 2019

BUY
$39.11 - $75.15 $47,557 - $91,382
1,216 Added 6.58%
19,701 $826,000
Q3 2018

Oct 22, 2018

BUY
$65.0 - $82.15 $110,240 - $139,326
1,696 Added 10.1%
18,485 $1.4 Million
Q2 2018

Jul 23, 2018

BUY
$27.2 - $74.35 $456,660 - $1.25 Million
16,789 New
16,789 $1.21 Million

Others Institutions Holding RGNX

About REGENXBIO Inc.


  • Ticker RGNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,230,000
  • Market Cap $329M
  • Description
  • REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprie...
More about RGNX
Track This Portfolio

Track Texas Permanent School Fund Portfolio

Follow Texas Permanent School Fund and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Texas Permanent School Fund, based on Form 13F filings with the SEC.

News

Stay updated on Texas Permanent School Fund with notifications on news.